Year: 2026

Shelton, CT, April 13, 2026 (GLOBE NEWSWIRE) — Hubbell Incorporated (NYSE: HUBB) today announced it will release its first quarter 2026 financial results prior to the opening of the market on April 30th, 2026. The Company will then webcast its Analysts’ Conference Call to discuss the results at 10:00 AM ET.  The full text of the press release announcing the results will be posted on Hubbell’s corporate website under the Press Release section. You can also access this information by going to www.hubbell.com and selecting “Investors” from the options at the bottom of the page and then “Press Releases” from the drop-down menu.  The live audio of the conference call and accompanying materials will also be available and can be accessed by visiting Hubbell’s Events and Presentations section. You...

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S.-headquartered drybulk shipowner focused on the global transportation of commodities, today issued the following statement regarding Diana Shipping Inc.’s (“Diana”) letter to Genco shareholders: The Genco Board of Directors and management team are committed to maximizing value for Genco shareholders. Today, Diana issued a letter as part of its efforts to take control of Genco through an inadequate acquisition proposal and through replacing the entire Genco Board with its handpicked nominees. We encourage shareholders to ignore Diana’s letter and not be distracted by its inflammatory and misleading statements. Instead, Genco shareholders should keep in mind the following:Genco’s comprehensive...

EMERYVILLE, Calif., April 13, 2026 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge”, “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the 25th Annual Needham Virtual Healthcare Conference taking place April 13–16, 2026. Kristen Fortney, PhD, CEO and co-founder, is scheduled to participate in a fireside chat on Thursday, April 16 from 3:00 PM to 3:30 PM EDT. Kristen Fortney, Dov Goldstein, MD, CFO, and BJ Sullivan, PhD, Chief Strategy Officer, will participate in one-on-one meetings. To access the live webcast of the presentation, register here. Replays of the webcast will be available in the investor section of the Company’s website...

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Rezolve Ai PLC (NASDAQ: RZLV), the global leader in AI-native commerce infrastructure, today announced it will host an investor call and Q&A open to shareholders of both Rezolve Ai and Commerce.com, Inc. (NASDAQ: CMRC) on Wednesday, April 15, 2026, at 0800 Eastern Time. The call will be hosted by Daniel M. Wagner, Chairman and CEO of Rezolve Ai, and will follow the agenda below:Introduction to Rezolve Ai: the company, its technology platform and its financial trajectory Overview of the proposed combination with Commerce.com: the strategic rationale for the proposed offer The opportunity ahead: the value creation path and what it means for shareholders of both companies Open Q&ACommerce.com is guiding for as little as 1.5% revenue growth in the year ahead. Rezolve Ai is on...

WALTHAM, Mass., April 13, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease (“IBD”) and other immune-mediated diseases, today announced that it has commenced an underwritten public offering of $300.0 million of shares of its common stock. In addition, the Company is expected to grant the underwriters of the offering an option for a period of 30 days to purchase an additional $45.0 million of shares of common stock at the public offering price, less the underwriting discount. All of the shares of common stock in the offering will be sold by Spyre. The offering is subject to market and other conditions,...

SAN RAFAEL, BULACAN, PHILIPPINES, April 13, 2026 (GLOBE NEWSWIRE) — One and one Green Technologies. INC (Nasdaq: YDDL) (“One and One” or the “Company”) (NASDAQ: YDDL), a Philippines-based recycler holding a government-issued license in the Philippines to import and process hazardous waste as raw materials, today announced the closing of its previously announced follow-on offering to two institutional investors for the sale of 1,733,334 units (the “Units”) in a follow-on offering of its securities at a purchase price of $7.50 per Unit, each unit consisting of one Class A ordinary share, par value $ 0.0001 per share (“Class A Ordinary Share”), and one warrant (“Warrant”) to purchase one and a half Class A Ordinary Shares (together, the “Securities”). The gross proceeds from the offering were $13 million, before deducting...

PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, announced that Dr. Gilles Guillemette and Dr. Anthony DiMarco have been appointed to its Board of Directors, effective April 15, 2026. The Company also announced it is moving to a 7-person Board of Directors with six Independent Directors and the CEO, and that it will create a Strategy and Technology Committee of the Board of Directors. Dr. Guillemette has more than 30 years of executive experience in animal health therapeutics. He has held executive positions at Elanco, Bayer, Henry Schein, Chewy, and Trupanion, where he had significant P&L responsibilities, led strategy, business development and finance...

HOUSTON, April 13, 2026 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that it will release its first quarter 2026 results after the New York Stock Exchange closes on Tuesday, May 5, 2026. This release will be followed by a conference call for investors on Wednesday, May 6, 2026, at 9:00 a.m. Central Time (10:00 a.m. Eastern). The full text of the release will be available on Par Pacific’s website at http://www.parpacific.com. Par Pacific First Quarter 2026 Earnings Conference CallWednesday, May 6, 20269:00 a.m. Central time (10:00 a.m. Eastern)Dial-in number: 1-833-974-2377 (toll-free) or 1-412-317-5782 (toll) Individuals who would like to participate should dial the applicable dial-in number at least 10 minutes before the scheduled conference call time. To access the live audio webcast...